Crystallization of iodixanol in isopropanol and methanol

A technology of iodixanol and isopropanol, used in organic chemistry, separation/purification of carboxylic acid amides, etc.

Active Publication Date: 2010-09-15
GE HEALTHCARE AS
View PDF15 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This is a challenge because even small amounts of water in the mother liquor of crystallization can significantly increase the solubility of iodixanol

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystallization of iodixanol in isopropanol and methanol

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039]Crude iodixanol dissolved in water (about 700 kg, HPLC purity 83-84%) was concentrated on a falling film evaporator, followed by conventional distillation to a viscous solution containing about 0.17-0.18 L water / kg Crude iodixanol. Methanol (1400 L) was added at reflux and the solution was inoculated with crystalline iodixanol (approximately 2-3 kg). Isopropanol (540 L) was added at a rate of 50-100 L / h under reflux. After 30 hours, more isopropanol (approximately 700 L) was added at the same low rate. A third portion of isopropanol may be added. At least 65 hours after inoculation and when the concentration of the mother liquor is 7.0 w / v% or less, the suspension is filtered on a pressure filter at 60° C. under a nitrogen pressure of up to 1 bar. The formed filter cake was washed with methanol at approximately 60°C (total 750 L). The HPLC purity of the crystals was 98.0-98.5%, and the crystallization yield was 85-90% relative to crude iodixanol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to crystallization of iodixanol in isopropanol and methanol, concretely relates to a process for the manufacture of iodixanol by performing a crystallization process of the crude product in a solvent mixture comprising water, methanol and isopropanol. The crude product may be obtained in aqueous solution from dimerisation of 5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-isophthalamide (''Compound A'').

Description

[0001] Cross-Referenced Related Applications [0002] This application claims the benefit of priority under 35 U.S.C. §119(e) of US Provisional Application No. 61 / 227,104, filed July 21, 2009, the entire disclosure of which is hereby incorporated by reference. technical field [0003] The present invention relates to iodixanol (1,3-bis(acetylamino)-N,N'-bis[3,5-bis(2,3-dihydroxypropylaminocarbonyl)-2,4,6-tri Production of iodophenyl]-2-hydroxypropane). Background technique [0004] Iodixanol is available under the brand name Visipaque TM Nonproprietary name of the chemical drug marketed under Non-Ionic X-ray Contrast Media. Visipaque TM is one of the most widely used reagents in diagnostic X-ray methods and is manufactured in large quantities. [0005] The manufacture of such non-ionic X-ray contrast agents involves the production of chemical substances (known as primary production) followed by formulation into pharmaceutical products (known as secondary production). Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C237/46C07C231/24
CPCC07C231/24C07C237/46
Inventor O·M·霍梅斯泰德
Owner GE HEALTHCARE AS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap